Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bio-Techne (TECH) FCF Margin (2016 - 2025)

Historic FCF Margin for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to 25.85%.

  • Bio-Techne's FCF Margin fell 2500.0% to 25.85% in Q4 2025 from the same period last year, while for Dec 2025 it was 18.35%, marking a year-over-year decrease of 29200.0%. This contributed to the annual value of 21.03% for FY2025, which is 6600.0% up from last year.
  • Per Bio-Techne's latest filing, its FCF Margin stood at 25.85% for Q4 2025, which was down 2500.0% from 7.75% recorded in Q3 2025.
  • Over the past 5 years, Bio-Techne's FCF Margin peaked at 2326.25% during Q3 2022, and registered a low of 7.75% during Q3 2025.
  • For the 5-year period, Bio-Techne's FCF Margin averaged around 137.73%, with its median value being 22.77% (2022).
  • Per our database at Business Quant, Bio-Techne's FCF Margin skyrocketed by 23098100bps in 2022 and then crashed by -23097200bps in 2023.
  • Bio-Techne's FCF Margin (Quarter) stood at 33.73% in 2021, then plummeted by -36bps to 21.46% in 2022, then increased by 17bps to 25.04% in 2023, then rose by 4bps to 26.1% in 2024, then dropped by -1bps to 25.85% in 2025.
  • Its FCF Margin stands at 25.85% for Q4 2025, versus 7.75% for Q3 2025 and 29.44% for Q2 2025.